163 related articles for article (PubMed ID: 23002208)
41. Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors.
Cavallo F; Feldman DR; Barchi M
Int J Dev Biol; 2013; 57(2-4):273-80. PubMed ID: 23784838
[TBL] [Abstract][Full Text] [Related]
42. Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation.
Wu J; Lei H; Zhang J; Chen X; Tang C; Wang W; Xu H; Xiao W; Gu W; Wu Y
Oncotarget; 2016 Sep; 7(37):58995-59005. PubMed ID: 27449295
[TBL] [Abstract][Full Text] [Related]
43. Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor?
Suer E; Mermerkaya M; Gülpınar Ö; Afandiyev F; Baltacı S; Türkölmez K; Bedük Y
J Urol; 2013 Dec; 190(6):2081-5. PubMed ID: 23764076
[TBL] [Abstract][Full Text] [Related]
44. Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer.
Lu CS; Shieh GS; Wang CT; Su BH; Su YC; Chen YC; Su WC; Wu P; Yang WH; Shiau AL; Wu CL
Oncotarget; 2017 May; 8(19):30844-30858. PubMed ID: 27244887
[TBL] [Abstract][Full Text] [Related]
45. Genomic evolution and chemoresistance in germ-cell tumours.
Taylor-Weiner A; Zack T; O'Donnell E; Guerriero JL; Bernard B; Reddy A; Han GC; AlDubayan S; Amin-Mansour A; Schumacher SE; Litchfield K; Turnbull C; Gabriel S; Beroukhim R; Getz G; Carter SL; Hirsch MS; Letai A; Sweeney C; Van Allen EM
Nature; 2016 Nov; 540(7631):114-118. PubMed ID: 27905446
[TBL] [Abstract][Full Text] [Related]
46. Effects of curcumin on bleomycin‑induced oxidative stress in malignant testicular germ cell tumors.
Cort A; Ozdemir E; Timur M; Ozben T
Mol Med Rep; 2012 Oct; 6(4):860-6. PubMed ID: 22825355
[TBL] [Abstract][Full Text] [Related]
47. Animacroxam, a Novel Dual-Mode Compound Targeting Histone Deacetylases and Cytoskeletal Integrity of Testicular Germ Cell Cancer Cells.
Steinemann G; Dittmer A; Kuzyniak W; Hoffmann B; Schrader M; Schobert R; Biersack B; Nitzsche B; Höpfner M
Mol Cancer Ther; 2017 Nov; 16(11):2364-2374. PubMed ID: 28838999
[TBL] [Abstract][Full Text] [Related]
48. Repair shielding of platinum-DNA lesions in testicular germ cell tumors by high-mobility group box protein 4 imparts cisplatin hypersensitivity.
Awuah SG; Riddell IA; Lippard SJ
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):950-955. PubMed ID: 28096358
[TBL] [Abstract][Full Text] [Related]
49. Cobalt and nickel stabilize stem cell transcription factor OCT4 through modulating its sumoylation and ubiquitination.
Yao Y; Lu Y; Chen WC; Jiang Y; Cheng T; Ma Y; Lu L; Dai W
PLoS One; 2014; 9(1):e86620. PubMed ID: 24497960
[TBL] [Abstract][Full Text] [Related]
50. Growth and chemotherapy of a human germ-cell tumour line (GCT 27).
Schlappack OK; Bush C; Delic JI; Steel GG
Strahlenther Onkol; 1989 Jul; 165(7):541. PubMed ID: 2473535
[No Abstract] [Full Text] [Related]
51. Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity.
Schaffrath J; Schmoll HJ; Voigt W; Müller LP; Müller-Tidow C; Mueller T
PLoS One; 2017; 12(6):e0178930. PubMed ID: 28591197
[TBL] [Abstract][Full Text] [Related]
52. 4-(3-Halo/amino-4,5-dimethoxyphenyl)-5-aryloxazoles and -N-methylimidazoles that are cytotoxic against combretastatin A resistant tumor cells and vascular disrupting in a cisplatin resistant germ cell tumor model.
Schobert R; Biersack B; Dietrich A; Effenberger K; Knauer S; Mueller T
J Med Chem; 2010 Sep; 53(18):6595-602. PubMed ID: 20731355
[TBL] [Abstract][Full Text] [Related]
53. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
[TBL] [Abstract][Full Text] [Related]
54. MAD2γ, a novel MAD2 isoform, reduces mitotic arrest and is associated with resistance in testicular germ cell tumors.
López-Saavedra A; Ramírez-Otero M; Díaz-Chávez J; Cáceres-Gutiérrez R; Justo-Garrido M; Andonegui MA; Mendoza J; Downie-Ruíz Á; Cortés-González C; Reynoso N; Castro-Hernández C; Domínguez-Gómez G; Santibáñez M; Fabián-Morales E; Pruefer F; Luna-Maldonado F; González-Barrios R; Herrera LA
Cell Cycle; 2016 Aug; 15(15):2066-76. PubMed ID: 27315568
[TBL] [Abstract][Full Text] [Related]
55. Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.
Kelland LR; Mistry P; Abel G; Freidlos F; Loh SY; Roberts JJ; Harrap KR
Cancer Res; 1992 Apr; 52(7):1710-6. PubMed ID: 1312897
[TBL] [Abstract][Full Text] [Related]
56. Reciprocal epigenetic remodeling controls testicular cancer hypersensitivity to hypomethylating agents and chemotherapy.
Singh R; Fazal Z; Bikorimana E; Boyd RI; Yerby C; Tomlin M; Baldwin H; Shokry D; Corbet AK; Shahid K; Hattab A; Freemantle SJ; Spinella MJ
Mol Oncol; 2022 Feb; 16(3):683-698. PubMed ID: 34482638
[TBL] [Abstract][Full Text] [Related]
57. Screening for intratubular germ cell neoplasia of the testis using OCT4 immunohistochemistry.
Jones TD; MacLennan GT; Bonnin JM; Varsegi MF; Blair JE; Cheng L
Am J Surg Pathol; 2006 Nov; 30(11):1427-31. PubMed ID: 17063084
[TBL] [Abstract][Full Text] [Related]
58. The Y-encoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors.
Li Y; Tabatabai ZL; Lee TL; Hatakeyama S; Ohyama C; Chan WY; Looijenga LH; Lau YF
Hum Pathol; 2007 Oct; 38(10):1470-81. PubMed ID: 17521702
[TBL] [Abstract][Full Text] [Related]
59. A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma.
Kerley-Hamilton JS; Pike AM; Li N; DiRenzo J; Spinella MJ
Oncogene; 2005 Sep; 24(40):6090-100. PubMed ID: 15940259
[TBL] [Abstract][Full Text] [Related]
60. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
